Genetic ablation of PTPN2 or PTPN1 in tumour cells augments signal transduction from type I and type II IFNs, increasing downstream effects, including cell growth arrest, increased production of immune cell chemoattractants and increased antigen presentation3. The gene discussed is PTPN2; the disease is neoplasm.